期刊文献+

吗啡抗体对吗啡依赖小鼠纳洛酮催促戒断症状的影响 被引量:2

THE EFFECT OF MORPHINE ANTIBODY ON WITHDRAWAL SYMPTOMS
下载PDF
导出
摘要 目的 :评价吗啡抗体对吗啡依赖小鼠纳洛酮催促戒断症状的影响。方法 :采用混合酸酐法制备琥珀酰吗啡 ,并分别与蓝载体 (BC ,bluecarrier)、KLH和BSA等 3种载体交联成酯 ;常规检测抗原性 ,并免疫小鼠 ,用ELISA法检测抗体滴度 ,纳洛酮催促戒断实验来评价 3种交联物对吗啡依赖性的影响。结果 :与 3种不同载体交联的吗啡酯在 5 μg·ml- 1 包板浓度时显示了良好的抗原性 ;用其免疫的 3组小白鼠的平均抗吗啡抗体滴度都超过 1∶16 0 0 0 ;对照组小鼠及BC组、KLH组、BSA组免疫小鼠在15min内跳跃次数依次为 :2 3 6 7±s 10 2 3次 ,0 88±s 1 36次 ,2 6 3±s 4 87次 ,10 0 0±s 5 71次 ,4组小鼠跳跃次数存在显著性差异 (P <0 0 1)。结论 :与 3种载体交联的吗啡酯都能诱导产生高滴度的抗体 ,对吗啡诱导的成瘾性抑制作用有所不同 ,其中BC偶联的吗啡酯较其它两种载体 -吗啡酯交联获得更好的效果。 Objective : To evaluate the effect of morphine antibody on withdrawal symptoms. Methods : The conjugates of morphine with BSA, KLH and blue carrier as carrier protein were prepared by mixed anhydride method, and their antigenicity was detected before immunization. The titres of antibody from mice immunized with three kinds of conjugates were determined respectively by ELISA. The withdrawal symptoms were induced by the opioid receptor antagonist naloxone to assess morphine dependence. Results : Three morphine conjugates showed good antigenicity in 5 μg·ml -1 coating concentration. The average titres of the three groups were over 1∶16 000. The number of skipping in the control, BC, KLH and BSA groups was 23 67± s 10 23,0 88± s 1 36,2 63± s 4 87 and 10 00± s 5 71 times in 15 minutes, respectively, showing significant difference ( P <0 01). Conclusion : Morphine-carrier conjugates can elicit high-titres antibody responses, and an inhibition on addiction of mice can be induced by morphine. Among three kinds of morphine conjugates, morphine-blue carrier shows a more effective, long-lasting anti-morphine immune response.
出处 《中国药物依赖性杂志》 CAS CSCD 2004年第1期29-32,共4页 Chinese Journal of Drug Dependence
基金 广州市科委攻关项目 2 0 0 2Z3-E4 10 2
关键词 吗啡抗体 吗啡依赖 小鼠 纳洛酮 戒断症状 混合酸酐法 免疫戒毒疗法 morphine conjugates immunity antibody
  • 相关文献

参考文献4

二级参考文献3

共引文献82

同被引文献17

  • 1师恩祎,江晓菁,白菡,中岛芳树.吗啡预处理的晚期心肌保护作用及其与诱导型一氧化氮合酶的关系[J].中华医学杂志,2004,84(11):891-895. 被引量:8
  • 2刘云,李剑波.甲基苯丙胺抗体、疫苗以及检测试纸研究进展[J].中国药物依赖性杂志,2005,14(5):330-332. 被引量:1
  • 3Seifert J,Metzner C,Paetzold W,et al.Detoxification of opiate addicts with multiple drug abuse:a comparison of buprenorphine vs methadone[J].Pharmaeopsychiatry,2002,35(5):159-64.
  • 4Bunce CJ,Loudon PT,Akers C,et al.Development of vaccines to help treat drug dependence [J].Curr Opin Mol Ther,2003,5 (1):58-63.
  • 5Janda KD.New directions in immunopharmacotherapy [J].Ernst Schering Res Found Workshop,2000,(32):315-46.
  • 6Akbarzadeh A,Mehraby M,Zarbakhsh M,et al.Design and synthesis of a morphine-6-succinyl-bovine serum albumin hapten for vaccine development [J].Biotechnol Appl Biochem,1999,30(2):139-45.
  • 7Kosten TR,Rosen M,BondJ,et al.Human therapeutic cocaine vaccine:safety and immunogenicity [J].Vaccine,2002,20 (7-8):1196-204.
  • 8Wainer BH,Fitch FW,Rothberg RM,et al.Morphine-3-succinyl-bovine serum albumin:an immunogenic hapten-protein conjugate[J].Science,1972,176 (39):1143-5.
  • 9Matsushita M,Hoffman TZ,AshleyJA,et al.Cocaine catalytic antibodies:the primary importance of linker effects [J].Bioorg Med Chem Lett,2001,11(2):87-90.
  • 10Landry DW,Zhao K,Yang GX,et al.Antibody-catalyzed degradation of cocaine[J].Science,1993,259(5103):1899-901.

引证文献2

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部